Sign Up to like & get
recommendations!
2
Published in 2022 at "Current pharmaceutical design"
DOI: 10.2174/1381612828666220412101447
Abstract: BACKGROUND Remifentanil reduces cough during extubation. Ramosetron, a 5-HT3 receptor antagonist, is a potent antiemetic. Regarding the antitussive property of 5-HT receptor agonists, ramosetron can mediate the cough reflex, as increasing the remifentanil requirement. The…
read more here.
Keywords:
effect ramosetron;
remifentanil;
ramosetron;
cough ... See more keywords